GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » China Health Group Inc (FRA:VNL1) » Definitions » Median PS Value

China Health Group (FRA:VNL1) Median PS Value : €0.00 (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is China Health Group Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. China Health Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.002. China Health Group's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is €0.00.

As of today (2024-06-23), China Health Group's share price is €0.0015. China Health Group's Median PS Value is €0.00. Therefore, China Health Group's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for China Health Group's Median PS Value or its related term are showing as below:

During the past 13 years, the highest Price to Median PS Value of China Health Group was 1.32. The lowest was 0.20. And the median was 0.60.

FRA:VNL1's Price-to-Median-PS-Value is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.795
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

China Health Group Median PS Value Historical Data

The historical data trend for China Health Group's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Group Median PS Value Chart

China Health Group Annual Data
Trend Dec12 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.06 0.02 -

China Health Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.01 0.01 -

Competitive Comparison of China Health Group's Median PS Value

For the Diagnostics & Research subindustry, China Health Group's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Group's Price-to-Median-PS-Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, China Health Group's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where China Health Group's Price-to-Median-PS-Value falls into.



China Health Group Median PS Value Calculation

China Health Group's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.002*0
=0.00

10-Year Median PS Ratio is 0.
China Health Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.002.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Health Group  (FRA:VNL1) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

China Health Group's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.0015/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Health Group Median PS Value Related Terms

Thank you for viewing the detailed overview of China Health Group's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Group (FRA:VNL1) Business Description

Traded in Other Exchanges
Address
Building 17, Jianwai SOHO, Chaoyang District, Beijing, CHN
China Health Group Inc is an investment holding company engaged in providing medical care facilities in the People's republic of china. The company provides provision of post launch market research, medical and medical market services (PM services), Provision of contracted pharmaceutical development services (PD services), Provision of contracted clinical research services (CR Services), Drugs technologies, and Other medical services. The majority of the revenue for the company comes from the provision of PM services.

China Health Group (FRA:VNL1) Headlines

No Headlines